Equities

Kiora Pharmaceuticals Inc

Kiora Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.48
  • Today's Change-0.026 / -5.10%
  • Shares traded50.49k
  • 1 Year change-88.28%
  • Beta-0.1800
Data delayed at least 15 minutes, as of Apr 25 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • KPRX:NAQ price moved over -12.51% to 0.5070
  • KPRX:NAQ price reached a new 52-week low of 0.4612 at 12:27 BST
  • KPRX:NAQ price rises above 200-day moving average to 0.5959 at 16:57 BST
  • KPRX:NAQ price rises above 50-day moving average to 0.6278 at 16:57 BST
  • KPRX:NAQ trading volume exceeds daily average by +22.04%
  • KPRX:NAQ price falls below 15-day moving average to 0.5070 at 10:30 BST
  • KPRX:NAQ price rises above 15-day moving average to 0.56 at 16:57 BST

Key statistics

On Thursday, Kiora Pharmaceuticals Inc (KPRX:NAQ) closed at 0.48, 6.40% above its 52-week low of 0.4511, set on Apr 22, 2024.
52-week range
Today
0.4511Apr 22 20245.25Apr 27 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.4906
High0.4935
Low0.475
Bid0.469
Offer0.48
Previous close0.48
Average volume250.96k
Shares outstanding26.26m
Free float26.03m
P/E (TTM)--
Market cap12.60m USD
EPS (TTM)-2.98
USD
Data delayed at least 15 minutes, as of Apr 25 2024 20:59 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.